i assume there's more money in other diseases especially if insurance companies continue to pay the astronomical prices for some of these new drugs, for example hepatitis C, cancer.

I assume when big pharma looks at pd, they see a disease where by the time they bring a new drug to market, there might be a "cure" of sorts or a less risky/cheaper DBS.

it was assumed when i was diagnosed in late 2001 there would be a cure in 5 years.

i wonder what the newly diagnosed are told by their neuros nowadays?


rytary doesn't seem all that great, could be wrong.
have to research DEPOMED and see if his optimism is justified.
seems too good to be true, 1-2 pills/day. i know pd'ers on stalevo, requip, amantadine that are doing well 12+ years after diagnosis but the advantage of just 1 drug is obvious in any disease even if the cost was slightly more.

let's hope for successful fetal and stem cell trials in 2015. keep exercising.